Abstract
The development of O-phosphotyrosine (pTyr) analogues is reviewed, along with their application in peptidomimetic ligands to proteins implicated in disease-states arising from dysfunctional intracellular signal transduction pathways. Salient features of chemical syntheses are critiqued, including those of established mimetics such as 4-(phosphonomethyl)phenylalanine (Pmp), 4- (phosphono)phenylalanine (Ppp) and 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp), their respective (α-methyl)phenylalanine analogues and “preorganised” side-chain cyclised pTyr mimetics. Syntheses of 4-(phosphinomethyl)phenylalanines are also described, as are “bone-directing” residues such as 4-(diphosphonomethyl)phenylalanine (dpmF), 3,4-(diphosphono)phenylalanine and 4- carboxymethyloxy-3-(phosphono)phenylalanine (CPP), capable of eliciting additional interactions with pTyr-binding subsites of specified proteins. The utility of [(4-phosphonomethyl)phenyl]propenoic acid in current developments is also discussed as a route to a range of α- and β-substituted pTyr mimetics, and to pTyr mimetics bearing the requisite β-vinyl functionality to facilitate macrocyclisation via olefin metathesis - of interest in the development of structures exhibiting global conformational constraint. Finally, developments in prodrug presentation of pTyr mimetics are also discussed.
Current Organic Chemistry
Title: O-Phosphotyrosine Analogues: Synthesis and Therapeutic Role in Modulation of Signal Transduction
Volume: 14 Issue: 5
Author(s): Nick J. Wardle, Harry R. Hudson and S. W. Annie Bligh
Affiliation:
Abstract: The development of O-phosphotyrosine (pTyr) analogues is reviewed, along with their application in peptidomimetic ligands to proteins implicated in disease-states arising from dysfunctional intracellular signal transduction pathways. Salient features of chemical syntheses are critiqued, including those of established mimetics such as 4-(phosphonomethyl)phenylalanine (Pmp), 4- (phosphono)phenylalanine (Ppp) and 4-(phosphonodifluoromethyl)phenylalanine (F2Pmp), their respective (α-methyl)phenylalanine analogues and “preorganised” side-chain cyclised pTyr mimetics. Syntheses of 4-(phosphinomethyl)phenylalanines are also described, as are “bone-directing” residues such as 4-(diphosphonomethyl)phenylalanine (dpmF), 3,4-(diphosphono)phenylalanine and 4- carboxymethyloxy-3-(phosphono)phenylalanine (CPP), capable of eliciting additional interactions with pTyr-binding subsites of specified proteins. The utility of [(4-phosphonomethyl)phenyl]propenoic acid in current developments is also discussed as a route to a range of α- and β-substituted pTyr mimetics, and to pTyr mimetics bearing the requisite β-vinyl functionality to facilitate macrocyclisation via olefin metathesis - of interest in the development of structures exhibiting global conformational constraint. Finally, developments in prodrug presentation of pTyr mimetics are also discussed.
Export Options
About this article
Cite this article as:
Wardle J. Nick, Hudson R. Harry and Annie Bligh W. S., O-Phosphotyrosine Analogues: Synthesis and Therapeutic Role in Modulation of Signal Transduction, Current Organic Chemistry 2010; 14 (5) . https://dx.doi.org/10.2174/138527210790601189
DOI https://dx.doi.org/10.2174/138527210790601189 |
Print ISSN 1385-2728 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5348 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements